Ana səhifə

Section I: Surgical Biology Chapter 1: Inflammatory Response references


Yüklə 3.38 Mb.
səhifə2/55
tarix24.06.2016
ölçüsü3.38 Mb.
1   2   3   4   5   6   7   8   9   ...   55

Chapter 2: Molecular and Cellular Biology: Genomics



REFERENCES

  1. Argyle DJ: Telomerase: a missing link between ageing, cancer and novel therapies? Vet J 175:149, 2008. PUBMED Abstract

  2. Barrett JG, Hao Z, Graf BK, et al: Inflammatory changes in ruptured canine cranial and human anterior cruciate ligaments. Am J Vet Res 66:2073, 2005. PUBMED Abstract

  3. Belle A, Tanay A, Bitincka L, et al: Quantification of protein half-lives in the budding yeast proteome. PNAS 103:13004, 2006. PUBMED Abstract

  4. Birmingham A, Anderson EM, Reynolds A, et al: 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3:199, 2006. PUBMED Abstract

  5. Black LL, Gaynor J, Adams C, et al: Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9:192, 2008. PUBMED Abstract

  6. Black LL, Gaynor J, Gahring D, et al: Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 8:272, 2007. PUBMED Abstract

  7. Boggs R, Wright Z, Stickney M, et al: MicroRNA expression in canine mammary cancer. Mamm Genome 19:561, 2008. PUBMED Abstract

  8. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33(suppl):228, 2003. PUBMED Abstract

  9. Burgener IA, Kovacevic A, Mauldin GN, et al: Cardiac troponins as indicators of acute myocardial damage in dogs. J Vet Intern Med 20:277, 2006. PUBMED Abstract

  10. Burton-Wurster N, Mateescu RG, Todhunter RJ, et al: Genes in canine articular cartilage that respond to mechanical injury: gene expression studies with Affymetrix Canine GeneChip. J Hered 97:821, 2005. PUBMED Abstract

  11. Campbell SE, Bennett D, Nasir L, et al: Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model. Rheumatology 44:735, 2005. PUBMED Abstract

  12. Campbell SE, Nasir L, Gault EA, et al: Preliminary studies of particle-mediated gene delivery to the joints of dogs. Vet Rec 160:476, 2007. PUBMED Abstract

  13. Castrillo J, Zeef L, Hoyle D, et al: Growth control of the eukaryote cell: a systems biology study in yeast. J Biol 6:4, 2007. PUBMED Abstract

  14. Chase K, Lawler DF, Carrier DR, et al: Genetic regulation of osteoarthritis: a QTL regulating cranial and caudal acetabular osteophyte formation in the hip joint of the dog (canis familiaris). Am J Med Genet 135:334, 2005. PUBMED Abstract

  15. Clements DN, Carter SD, Innes JF, et al: Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative-PCR. Arthritis Res Ther 8:R158, 2006. PUBMED Abstract

  16. Clements DN, Carter SD, Innes JF, et al: Gene expression profiling of normal and ruptured canine anterior cruciate ligaments. Osteoarthritis Cartilage 16:195, 2008. PUBMED Abstract

  17. Credille KM, Minor JS, Barnhart KF, et al: Transglutaminase 1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs. Br J Dermatol 161:265, 2009. PUBMED Abstract

  18. Cucchiarini M, Thurn T, Weimer A, et al: Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56:158, 2007. PUBMED Abstract

  19. da Silva MA, Yamada N, Clarke NM, et al: Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res 27:593, 2009. PUBMED Abstract

  20. DeBaise P, Capanna R: Clinical applications of BMPs. Injury 36(suppl 3):S43, 2005. PUBMED Abstract

  21. Draisma G, Boer R, Otto SJ, et al: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95:868, 2003. PUBMED Abstract

  22. Emerson MV, Lauer AK: Current and emerging therapies for the treatment of age-related macular degeneration. Clin Ophthalmol 2:377, 2008. PUBMED Abstract

  23. Feldmann M, Maini RN: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9:1245, 2003. PUBMED Abstract

  24. Fleischer S, Sharkey M, Mealey K, et al: Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model. AAPS J 10:110, 2008. PUBMED Abstract

  25. Fox S, Filichkin S, Mockler TC: Applications of ultra-high-throughput sequencing. Methods Mol Biol 553:79, 2009. PUBMED Abstract

  26. Freilich S, Massingham T, Bhattacharyya S, et al: Relationship between the tissue-specificity of mouse gene expression and the evolutionary origin and function of the proteins. Genome Biol 6:R56, 2005. PUBMED Abstract

  27. Games D, Adams D, Alessandrini R, et al: Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523, 1995. PUBMED Abstract

  28. Garcia DE, Baidoo EE, Benke PI, et al: Separation and mass spectrometry in microbial metabolomics. Curr Opin Microbiol 11:233, 2008. PUBMED Abstract

  29. Gaspar HB, Parsley KL, Howe S, et al: Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364:2181, 2004. PUBMED Abstract

  30. Hanna J, Wernig M, Markoulaki S, et al: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920, 2007. PUBMED Abstract

  31. Hannenhalli SS, Middleton RP, Levy S, et al: Identification and cross-species comparison of canine osteoarthritic gene regulatory cis-elements. Osteoarthritis Cartilage 14:830, 2006. PUBMED Abstract

  32. Hirschhorn JN, Lohmueller K, Byrne E, et al: A comprehensive review of genetic association studies. Gen Med 4:45, 2002. PUBMED Abstract

  33. Hsu WL, Huang HM, Liao JW, et al: Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. Vet J 180:116, 2009. PUBMED Abstract

  34. Karlsson EK, Lindblad-Toh K: Leader of the pack: gene mapping in dogs and other model organisms. Nat Rev Genet 9:713, 2008. PUBMED Abstract

  35. Kirkness EF, Bafna V, Halpern AL, et al: The dog genome: survey sequencing and comparative analysis. Science 301:1898, 2003. PUBMED Abstract

  36. Kotzsch M, Sieuwerts A, Grosser M, et al: Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res Treat 111:229, 2008. PUBMED Abstract

  37. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Am Med Assoc 279:1200, 1998.

  38. Lemburg AK, Meyer-Lindenberg A, Hewicker-Trautwein M: Immunohistochemical characterization of inflammatory cell populations and adhesion molecule expression in synovial membranes from dogs with spontaneous cranial cruciate ligament rupture. Vet Immunol Immunopathol 97:231, 2004. PUBMED Abstract

  39. Lindblad-Toh K, Wade CM, Mikkelsen TS, et al: Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803, 2005. PUBMED Abstract

  40. Lund JR, Paoloni M, Kurzman I, et al: Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies. Vet J 177:192, 2008. PUBMED Abstract

  41. Lyon MF: Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135, 1962. PUBMED Abstract

  42. Marguerat S, Wilhelm BT, Bähler J: Next-generation sequencing: applications beyond genomes. Biochem Soc Trans 36:1091, 2008. PUBMED Abstract

  43. Marschall Y, Distl O: Mapping quantitative trait loci for canine hip dysplasia in German Shepherd dogs. Mamm Genome 18:861, 2007. PUBMED Abstract

  44. Mateescu RG, Burton-Wurster NI, Tsai K, et al: Identification of quantitative trait loci for osteoarthritis of hip joints in dogs. Am J Vet Res 69:1294, 2008. PUBMED Abstract

  45. McCaw DL, Chan AS, Stegner AL, et al: Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clin Cancer Res 13:2496, 2007. PUBMED Abstract

  46. Mealey KL, Bentjen SA, Gay JM, et al: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenet Genomics 11:727, 2001. PUBMED Abstract

  47. Millanta F, Calandrella M, Citi S, et al: Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential. Vet Pathol 42:30, 2005. PUBMED Abstract

  48. Mohammadi M, Day PJR: Oligonucleotides used as template calibrators for general application in quantitative polymerase chain reaction. Anal Biochem 335:299, 2004. PUBMED Abstract

  49. Morgan RA, Dudley ME, Wunderlich JR, et al: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126, 2006. PUBMED Abstract

  50. Muir P, Oldenhoff WE, Hudson AP, et al: Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog 42:47, 2007. PUBMED Abstract

  51. Patterson EE, Minor KM, Tchernatynskaia AV, et al: A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse. Nat Genet 40:1235, 2008. PUBMED Abstract

  52. Paulson SK, Engel L, Reitz B, et al: Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27:1133, 1999. PUBMED Abstract

  53. Pele M, Tiret L, Kessler JL, et al: SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet 14:1417, 2005. PUBMED Abstract

  54. Pelham JT, Irwin PJ, Kay PH: Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders. Res Vet Sci 74:101, 2003. PUBMED Abstract

  55. Pontius JU, Mullikin JC, Smith DR, et al: Initial sequence and comparative analysis of the cat genome. Genome Res 17:1675, 2007. PUBMED Abstract

  56. Pontius JU, O’Brien SJ: Genome annotation resource fields (GARFIELD): a genome browser for Felis catus. J Hered 98:386, 2007. PUBMED Abstract

  57. Randolph JE, Scarlett J, Stokol T, et al: Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J Vet Intern Med 18:81, 2004. PUBMED Abstract

  58. Rans TS, England R: The evolution of gene therapy in X-linked severe combined immunodeficiency. Ann Allergy Asthma Immunol 102:357, 2009. PUBMED Abstract

  59. Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971, 2006. PUBMED Abstract

  60. Riley JH, Allan CJ, Lai E, et al: The use of single nucleotide polymorphisms in the isolation of common disease genes. Pharmacogenomics 1:39, 2000. PUBMED Abstract

  61. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 273:1516, 1996. PUBMED Abstract

  62. Rogers S, Girolami M, Kolch W, et al: Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics 24:2894, 2008. PUBMED Abstract

  63. Ross JS, Fletcher JA, Linette GP, et al: The HER-2/neu gene and protein in breast cancer: biomarker and target of therapy. Oncologist 8:307, 2003. PUBMED Abstract

  64. Salmon Hillbertz NHC, Isaksson M, Karlsson EK, et al: Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs. Nat Genet 39:1318, 2007. PUBMED Abstract

  65. Santangelo AM, de Souza FSJ, Franchini LF, et al: Ancient exaptation of a CORE-SINE retroposon into a highly conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PLoS Genet 3:e166, 2007. PUBMED Abstract

  66. Sargan DR, Aguirre-Hernandez J, Galibert F, et al: An extended microsatellite set for linkage mapping in the domestic dog. J Hered 98:221, 2007. PUBMED Abstract

  67. Schmoekel HG, Weber FE, Hurter K, et al: Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J Small Anim Pract 46:17, 2005. PUBMED Abstract

  68. Schmokel HG, Weber FE, Seiler G, et al: Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg 33:112, 2004. PUBMED Abstract

  69. Schober KE, Cornand C, Kirbach B, et al: Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 221:381, 2002. PUBMED Abstract

  70. Schroder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320, 2009. PUBMED Abstract

  71. Scott SW: Genetics of primary generalized osteoarthritis. Mol Genet Metab 77:31, 2002. PUBMED Abstract

  72. Shen J, Samul R, Silva RL, et al: Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 13:225, 2005.

  73. Shendure J, Ji H: Next-generation DNA sequencing. Nat Biotechnol 26:1135, 2008. PUBMED Abstract

  74. Sleeper MM, Bish LT, Sweeney HL: Gene therapy in large animal models of human cardiovascular genetic disease. ILAR J 50:199, 2009. PUBMED Abstract

  75. Stanton H, Rogerson FM, East CJ, et al: ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648, 2005. PUBMED Abstract

  76. Stephens TD, Bunde CJW, Fillmore BJ: Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol 59:1489, 2000. PUBMED Abstract

  77. Stieger K, Lheriteau E, Moullier P, et al: AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J 50:206, 2009. PUBMED Abstract

  78. Stoker A, Cook J, Kuroki K, et al: Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs. J Orthop Surg Res 1:8, 2006. PUBMED Abstract

  79. Sutter NB, Eberle MA, Parker HG, et al: Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 14:2388, 2004. PUBMED Abstract

  80. Tabar MD, Roura X, Francino O, et al: Detection of Leishmania infantum by real-time PCR in a canine blood bank. J Small Anim Pract 49:325, 2008. PUBMED Abstract

  81. Tanzer A, Stadler PF: Molecular evolution of a microRNA cluster. J Mol Biol 339:327, 2004. PUBMED Abstract

  82. Todhunter R, Mateescu R, Lust G, et al: Quantitative trait loci for hip dysplasia in a crossbreed canine pedigree. Mamm Genome 16:720, 2005. PUBMED Abstract

  83. Um SY, Chung MW, Kim KB, et al: Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats. Anal Chem 81:4734, 2009. PUBMED Abstract

  84. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:0034.1, 2002. PUBMED Abstract

  85. VanGuilder HD, Vrana KE, Freeman WM: Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44:619, 2008. PUBMED Abstract

  86. Wang Z, Chamberlain JS, Tapscott SJ, et al: Gene therapy in large animal models of muscular dystrophy. Institute of Laboratory Animal Resources Journal 50:187, 2009. PUBMED Abstract

  87. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57, 2009. PUBMED Abstract

  88. Watson JD, Crick FJ: Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737, 1953. PUBMED Abstract

  89. Watson JD, Jordan E: The human genome program at the National Institutes of Health. Genomics 5:654, 1989. PUBMED Abstract

  90. Whitfield P, Noble PJ, Major H, et al: Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 1:215, 2005.

  91. Wilkins MR, Sanchez JC, Gooley AA, et al: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13:19, 1996. PUBMED Abstract

  92. Wilkinson LS, Davies W, Isles AR: Genomic imprinting effects on brain development and function. Nat Rev Neurosci 8:832, 2007. PUBMED Abstract

  93. Wilson CR, Regnier FE, Knapp DW, et al: Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma. Vet Comp Oncol 6:171, 2008. PUBMED Abstract

  94. Ye L, Chang JC, Lin C, et al: Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. PNAS 106:9826, 2009. PUBMED Abstract

  95. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917, 2007. PUBMED Abstract

Chapter 3: Biomarkers in Clinical Medicine



REFERENCES

  1. Abbasi F, Chu JW, Lamendola C, et al: Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53:585, 2004. PUBMED Abstract

  2. Alsemgeest SP, van’t Klooster GA, van Miert AS, et al: Primary bovine hepatocytes in the study of cytokine induced acute-phase protein secretion in vitro. Vet Immunol Immunopathol 53:179, 1996. PUBMED Abstract

  3. Ameye LG, Deberg M, Oliveria M, et al: The chemical biomarkers C2C, Coll2-1 and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis Rheum 56:3336, 2007. PUBMED Abstract

  4. Andersson M, Sevelius E: Abnormal microheterogeneity of haptoglobin in serum from dogs with various diseases. Vet Rec 148:14, 2001. PUBMED Abstract

  5. Andersson M, Stenstrom M, Vatne M, et al: Disease-related variations of the glycosylation of haptoglobin in the dog. J Comp Pathol 119:227, 1998. PUBMED Abstract

  6. Appleton DJ, Rand JS, Sunvold GD: Plasma leptin concentrations in cats: reference range, effect of weight gain and relationship with adiposity as measured by dual energy X-ray absorptiometry. J Feline Med Surg 2:191, 2000. PUBMED Abstract

  7. Archer CW, Morrison EH, Bayliss MT, et al: The development of articular-cartilage. 2. The spatial and temporal patterns of glycosaminoglycans and small leucine-rich proteoglycans. J Anat 189:23, 1996. PUBMED Abstract

  8. Arican M, Carter SD, Bennett D, May C: Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies. Res Vet Sci 56:290, 1994. PUBMED Abstract

  9. Atkinson AJ, Colburn WA, DeGruttola VG, et al: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89, 2001.

  10. Bathen-Noethen A, Carlson R, Menzel D, et al: Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 22:1149, 2008. PUBMED Abstract

  11. Baumann H, Gauldie J: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147, 1990. PUBMED Abstract

  12. Beutler B, Cerami A: Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunol Res 5:281, 1986. PUBMED Abstract

  13. Billinghurst RC, Buxton EM, Edwards MG, McGraw MS, McIlwraith CW: Use of an anti-neoepitope antibody for identification of type-II collagen degradation in equine articular cartilage. Am J Vet Res 62:1031, 2001. PUBMED Abstract

  14. Billinghurst RC, Dahlberg L, Ionescu M, et al: Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilage. J Clin Invest 99:1534, 1997. PUBMED Abstract

  15. Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729, 1997. PUBMED Abstract

  16. Blecher C, Yaqub R, Fawthrop F: Synovial fluid chondroitin and keratin sulphate epitopes, glycosaminoglycans and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56:299, 1997. PUBMED Abstract

  17. Bohnhorst JO, Hanssen I, Moen T: Immune-mediated fever in the dog: occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum. Acta Vet Scand 43:165, 2002. PUBMED Abstract

  18. Borer LR, Peel JE, Seewald W, et al: Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. Am J Vet Res 64:1429, 2003. PUBMED Abstract

  19. Brandt KD, Thonar EJM: Lack of association between serum keratan sulfate concentrations and cartilage changes of osteoarthritis after transection of the anterior cruciate ligament in the dog. Arthritis Rheum 32:647, 1989. PUBMED Abstract

  20. Briot K, Roux C, Gossec L, et al: Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. J Rheumatol 35:310, 2008. PUBMED Abstract

  21. Bruun JM, Pedersen SB, Richelsen B: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86:1267, 2001. PUBMED Abstract

  22. Bullo M, Peeraully MR, Trayhurn P: Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. Am J Physiol Endocrinol Metab 289:E62, 2005. PUBMED Abstract

  23. Campion GV, McCrae F, Schnitzer TJ, et al: Levels of keratan sulphate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 34:1254, 1991. PUBMED Abstract

  24. Carlson CS, Guilak F, Vail TP, et al: Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee. J Orthop Res 20:92, 2002. PUBMED Abstract

  25. Carlson CS, Loeser RF, Johnstone B, et al: Osteoarthritis in Cynomolgus macaques II: detection of modulated proteoglycan epitopes in cartilage and synovial fluid. J Orthop Res 13:399, 1995. PUBMED Abstract

  26. Caspi D, Baltz ML, Snel F, et al: Isolation and characterization of C-reactive protein from the dog. Immunology 53:307, 1984. PUBMED Abstract

  27. Caspi D, Snel FW, Batt RM, et al: C-reactive protein in dogs. Am J Vet Res 48:919, 1987. PUBMED Abstract

  28. Caterson B, Hughes CE, Johnstone B: Immunological markers of cartilage proteoglycan metabolism in animal and human osteoarthritis. In Kuettner KE, editor: Articular cartilage and osteoarthritis, New York, 1992, Raven Press, p 415.

  29. Caterson B, Hughes CE, Roughley P, Mort JS: Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis. Acta Orthop Scand Suppl 66(suppl 266):121, 1995. PUBMED Abstract

  30. Caterson B, Mahmoodian F, Sorrell JM, et al: Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 97:411, 1990. PUBMED Abstract

  31. Ceciliani F, Giordano A, Spagnolo V: The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 9:211, 2002. PUBMED Abstract

  32. Ceciliani F, Grossi C, Giordano A, et al: Decreased sialylation of the acute phase protein alpha1-acid glycoprotein in feline infectious peritonitis (FIP). Vet Immunol Immunopathol 99:229, 2004. PUBMED Abstract

  33. Ceron JJ, Eckersall PD, Martynez-Subiela S: Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 34:85, 2005. PUBMED Abstract

  34. Ceron JJ, Martinez-Subiela S, Ohno K, et al: A seven-point plan for acute phase protein interpretation in companion animals. Vet J 177:6, 2008. PUBMED Abstract

  35. Chaganti RK, Kelman A, Lui L, et al: Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis Cartilage 16:566, 2008. PUBMED Abstract

  36. Chan SS, Kent GN, Will RK: A sensitive assay for the measurement of serum chondroitin sulfate 3B3(-) epitope levels in human rheumatic diseases. Clin Exp Rheumatol 19:533, 2001. PUBMED Abstract

  37. Charni N, Juillet F, Garnero P: Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 52:1081, 2005. PUBMED Abstract

  38. Chiellini C, Santini F, Marsili A, et al: Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 89:2678, 2004. PUBMED Abstract

  39. Christgau S, Garnero P, Fledelius C, et al: Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29:209, 2001. PUBMED Abstract

  40. Christiansen T, Richelsen B, Bruun JM: Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29:146, 2005. PUBMED Abstract

  41. Chu Q, Lopez M, Hayashi K, et al: Elevation of a collagenase generated type II collagen neoepitope and a proteoglycan epitope in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 10:662, 2002. PUBMED Abstract

  42. Church TS, Willis MS, Priest EL, et al: Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 29:675, 2005. PUBMED Abstract

  43. Cicuttini FM, Baker JR, Spector TD: The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23:1221, 1996. PUBMED Abstract

  44. Conner JG, Eckersall PD, Ferguson J, et al: Acute phase response in the dog following surgical trauma. Res Vet Sci 45:107, 1988. PUBMED Abstract

  45. Considine RV, Sinha MK, Heiman ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292, 1996. PUBMED Abstract

  46. Cope AP: Measurement of glycosaminoglycan release from cartilage explants. In Mort JS, Roughley PJ, editors: Arthritis research, vol 135, Totowa, NJ, 2007, Humana Press, p 201.

  47. Croucher LJ, Hollander AP: Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage. Mol Pathol 52:323, 1999. PUBMED Abstract

  48. Deberg M, Labasse A, Christgau S, et al: New serum biochemical markers (Coll 2-1 and Coll-2-1NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 13:258, 2005. PUBMED Abstract

  49. DiCesare PE, Carlson CSN, Stolerman ES, et al: Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 14:946, 1996.

  50. DiCesare P, Hauser N, Lehman D, et al: Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354:237, 1994. PUBMED Abstract

  51. Dinarello CA: Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311:1413, 1984. PUBMED Abstract

  52. Dumond H, Presle N, Terlain B, et al: Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118, 2003. PUBMED Abstract

  53. Duthie S, Eckersall PD, Addie DD, et al: Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec 141:299, 1997. PUBMED Abstract

  54. Ebersole JL, Cappelli D: Acute-phase reactants in infections and inflammatory diseases. Periodontol 2000 23:19, 2000. PUBMED Abstract

  55. Eckersall PD: Acute phase proteins as markers of inflammatory lesions. Comp Haematol Int 5:93, 1995.

  56. Eckersall PD: The time is right for acute phase protein assays. Vet J 168:3, 2004.

  57. Eckersall PD, Conner JG: Bovine and canine acute phase proteins. Vet Res Commun 12:169, 1988.

  58. Eckersall PD, Harvey MJ, Ferguson JM, et al: Acute phase proteins in canine pregnancy (Canis familiaris). J Reprod Fertil Suppl 47:159, 1993. PUBMED Abstract

  59. Eisele I, Wood IS, German AJ, et al: Adipokine gene expression in dog adipose tissues and dog white adipocytes differentiated in primary culture. Horm Metab Res 37:474, 2005. PUBMED Abstract

  60. Engeli S, Schling P, Gorzelniak K, et al: The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35:807, 2003. PUBMED Abstract

  61. Esposito K, Pontillo A, DiPalo C, et al: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799, 2003. PUBMED Abstract

  62. Evans CH, Mears DC, Stanitski CL: Ferrographic analysis of wear in human joints: evaluation by comparison with arthroscopic examination of symptomatic knees. J Bone Joint Surg Br 64:572, 1982. PUBMED Abstract

  63. Eyre DR: Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res 427(suppl):S118, 2004. PUBMED Abstract

  64. Eyre DR, McDevitt CA, Billingham MEJ, Muir H: Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 188:823, 1980. PUBMED Abstract

  65. Eyre DR, Weis MA: The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence. Osteoarthritis Cartilage 17:423, 2009. PUBMED Abstract

  66. Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173, 1986. PUBMED Abstract

  67. Felson DT, Lohmander LS: Whither osteoarthritis biomarkers? Osteoarthritis Cartilage 17:419, 2009. PUBMED Abstract

  68. Fife G, Brandt KD: Extracellular matrix of cartilage: Glycoproteins. In Woessner JF, Howell DS, editor: Joint cartilage degradation, New York, 1993, Marcel Dekker, p 139.

  69. Fleming TR, DeMets DL: Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125:605, 1996.

  70. Folsom AR, Qamhieh HT, Wing RR, et al: Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 13:162, 1993. PUBMED Abstract

  71. Fournier T, Medjoubi NN, Porquet D: Alpha-1-acid glycoprotein. Biochim Biophys Acta 1482:157, 2000. PUBMED Abstract

  72. Fransson BA, Bergstrom A, Wardrop KJ, et al: Assessment of three automated assays for C-reactive protein determination in dogs. Am J Vet Res 68:1281, 2007. PUBMED Abstract

  73. Frisbie DD, Al-Sobayil F, Billinghurst RC, et al: Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 16:1196, 2008. PUBMED Abstract

  74. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448, 1999. PUBMED Abstract

  75. Ganu V, Goldberg R, Peppard J, et al: Inhibition of interleukin-1a–induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis Rheum 41:2143, 1998. PUBMED Abstract

  76. Garnero P, Ayral X, Rousseau JC, et al: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46:21, 2002. PUBMED Abstract

  77. Garnero P, Charni N, Juillet F, et al: Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 65:1639, 2006. PUBMED Abstract

  78. Garvican ER, Vaughan-Thomas A, Redmond C, Clegg PD: MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis. Connect Tissue Res 49:62, 2008. PUBMED Abstract

  79. Gayet C, Leray V, Saito M, et al: The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs. Br J Nutr 98:497, 2007. PUBMED Abstract

  80. German AC, German AJ, Wood IS, et al: Development and optimization of a primary cell culture system for feline adipocytes. Presented at 2009 British Small Animal Veterinary Association (BSAVA) Congress, April 3, 2009, Birmingham.

  81. German AJ, Hervera M, Hunter L, et al: Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 37:214, 2009. PUBMED Abstract

  82. Girling SL, Bell SC, Whitelock RG, et al: Use of biochemical markers of osteoarthritis to investigate the potential disease-modifying effect of tibial plateau levelling osteotomy. J Small Anim Pract 47:708, 2006. PUBMED Abstract

  83. Glant TT, Mikecz K, Roughley PJ, et al: Age-related changes protein-related epitopes of human articular-cartilage proteoglycans. Biochem J 236:71, 1986. PUBMED Abstract

  84. Goranov NV: Serum markers of lipid peroxidation, antioxidant enzymatic defense, and collagen degradation in an experimental (Pond-Nuki) canine model of osteoarthritis. Vet Clin Pathol 36:192, 2007. PUBMED Abstract

  85. Halasz K, Kassner A, Morgelin M, et al: COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 282:31166, 2007. PUBMED Abstract

  86. Harvey JW: Comparison between serum haptoglobin and alpha-2-globulin concentrations in dogs. Vet Clin Pathol 15:4, 1986. PUBMED Abstract

  87. Hayashi K, Kim SY, Lansdowne JL, et al: Evaluation of a collagenase generated osteoarthritis biomarker in naturally occurring canine cruciate disease. Vet Surg 38:117, 2009. PUBMED Abstract

  88. Hayashi S, Jinbo T, Iguchi K, et al: A comparison of the concentrations of C-reactive protein and alpha1-acid glycoprotein in the serum of young and adult dogs with acute inflammation. Vet Res Commun 25:117, 2001. PUBMED Abstract

  89. Hazell PK, Dent C, Fairclough JA: Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 38:953, 1995. PUBMED Abstract

  90. Hedbom E, Antonsson P, Hjerpe A, et al: Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132, 1992. PUBMED Abstract

  91. Hegemann N, Kohn B, Brunnberg L, Schmidt MF: Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 10:714, 2002. PUBMED Abstract

  92. Heikkila K, Ebrahim S, Lawlor DA: Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 44:937, 2008. PUBMED Abstract

  93. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621, 1990. PUBMED Abstract

  94. Henrotin Y, Deberg M, Dubuc JE, et al: Type II collagen peptides for measuring cartilage degradation. Biorheology 41:543, 2004. PUBMED Abstract

  95. Higgins MA, Berridge BR, Mills BJ, et al: Gene expression analysis of the acute phase response using a canine microarray. Toxicol Sci 74:470, 2003. PUBMED Abstract

  96. Hinek A, Reiner A, Poole AR: The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of the type II collagen (chondrocalcin). J Cell Biol 104:1435, 1987. PUBMED Abstract

  97. Hochepied T, Berger FG, Baumann H, et al: Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14:25, 2003. PUBMED Abstract

  98. Hoenig M, Thomaseth K, Waldron M, et al: Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 292:R227, 2007.

  99. Hogenesch H, Snyder PW, Scott-Moncrieff JC, et al: Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids. Clin Immunol Immunopathol 77:107, 1995. PUBMED Abstract

  100. Horadagoda NU, Knox KM, Gibbs HA, et al: Acute phase proteins in cattle: discrimination between acute and chronic inflammation. Vet Rec 144:437, 1999. PUBMED Abstract

  101. Hotamisligil GS, Arner P, Caro JF, et al: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409, 1995. PUBMED Abstract

  102. Hotamisligil GS, Murray DL, Choy LN, et al: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 91:4854, 1994. PUBMED Abstract

  103. Huebner JL, Kraus VB: Assessment of the utility of biomarkers of osteoarthritis in the guinea-pig. Osteoarthritis Cartilage 14:923, 2006. PUBMED Abstract

  104. Hughes CE, Caterson B, Fosang AJ: Monoclonal antibodies that specifically recognise neoepitope sequences generated by aggrecanase and matrix metalloproteinase cleavage of aggrecan—application to catabolism in situ and in vitro. Biochem J 305:799, 1995. PUBMED Abstract

  105. Hughes SS, Hicks DG, O’Keefe RJ, et al: Shared phenotypic expression of osteoblasts and chondrocytes in fracture callus. J Bone Miner Res 10:533, 1995. PUBMED Abstract

  106. Hummel KM, Neidhart M, Vilim V, et al: Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. Br J Rheumatol 37:721, 1998. PUBMED Abstract

  107. Innes J, Sharif M, Barr A: Relations between biochemical markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. Am J Vet Res 59:1530, 1998. PUBMED Abstract

  108. Innes JF, Little CB, Hughes CE, et al: Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis. Am J Vet Res 66:1679, 2005. PUBMED Abstract

  109. Innes JF, Little CB, Hughes CE, Caterson B: Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis. Am J Vet Res 66:1679, 2005. PUBMED Abstract

  110. Innes JF, Sharif M, Barr ARS: Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 60:1164, 1999. PUBMED Abstract

  111. Innes JF, Sharif M, Barr ARS: Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 60:1164, 1999. PUBMED Abstract

  112. Innes JF, Sharif M, Barr ARS. Relations between biochemical markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. AJVR 59:1530, 1998. PUBMED Abstract

  113. Ishioka K, Omachi A, Sagawa M, et al: Canine adiponectin: cDNA structure, mRNA expression in adipose tissues and reduced plasma levels in obesity. Res Vet Sci 80:127, 2006. PUBMED Abstract

  114. Jergens AE, Schreiner CA, Frank DE, et al: A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 17:291, 2003. PUBMED Abstract

  115. Jeusette IC, Detilleux J, Shibata H, et al: Effects of chronic obesity and weight loss on plasma ghrelin and leptin concentrations in dogs. Res Vet Sci 79:169, 2005. PUBMED Abstract

  116. Johnson KA, Hart RC, Chu Q, et al: Concentration of chondroitin sulphate epitopes 3B3 and 7D4 in synovial fluid after intra-articular and extracapsular reconstruction of the cranial cruciate ligament in dogs. Am J Vet Res 62:581, 2001. PUBMED Abstract

  117. Johnson KA, Hay CW, Chu Q, et al: Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. Am J Vet Res 63:775, 2002. PUBMED Abstract

  118. Juge-Aubry CE, Somm E, Pernin A, et al: Adipose tissue is a regulated source of interleukin-10. Cytokine 29:270, 2005. PUBMED Abstract

  119. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 34:457, 1991. PUBMED Abstract

  120. Kajikawa T, Furuta A, Onishi T, et al: Changes in concentrations of serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Vet Immunol Immunopathol 68:91, 1999. PUBMED Abstract

  121. Kaneko JJ: Serum proteins and the dysproteinemias. In Kaneko JJ, Harvey JW, Bruss ML, editors: Clinical biochemistry of domestic animals, ed 4, New York, 1997, Academic Press, p 117.

  122. Kielty CM, Hopkinson I: Collagen. The collagen family: structure, assembly, and organisation in the extracellular matrix. In Royce PM, Steinmann B, editors: Connective tissue and its heritable disorders, Wilmington, DE, 1993, Wiley-Liss, p 103.

  123. Knauper V, Lopez-Otin C, Smith B, et al: Biochemical characterization of human collagenase-3. J Biol Chem 271:1544, 1996. PUBMED Abstract

  124. Kopelman PG: Obesity as a medical problem. Nature 404:635, 2000. PUBMED Abstract

  125. Kriegler M, Perez C, DeFay K, et al: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45, 1988. PUBMED Abstract

  126. Kristiansen OP, Mandrup-Poulsen T: Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54(suppl 2):S114, 2005. PUBMED Abstract

  127. Kuribayashi T, Shimada T, Matsumoto M, et al: Determination of serum C-reactive protein (CRP) in healthy beagle dogs of various ages and pregnant beagle dogs. Exp Anim 52:387, 2003. PUBMED Abstract

  128. Kushner I, Mackiewicz A: Acute phase proteins as disease markers. Dis Markers 5:1, 1987. PUBMED Abstract

  129. Lebrecht A, Boehm D, Schmidt M, et al: Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics 6:177, 2009. PUBMED Abstract

  130. LeMay DR, LeMay LG, Kluger MJ, et al: Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am J Physiol 259:R126, 1990. PUBMED Abstract

  131. Lindhorst E, Vail TP, Guilak F, et al: Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis. J Orthop Res 18:269, 2000. PUBMED Abstract

  132. Little C, Smith S, Ghosh P: Histomorphological and immunohistochemical evaluation of joint changes in a model of osteoarthritis induced by lateral meniscectomy in sheep. J Rheumatol 24:2199, 1997. PUBMED Abstract

  133. Little CB, Flannery CR, Hughes CE, et al: Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 344:61, 1999. PUBMED Abstract

  134. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487, 2001. PUBMED Abstract

  135. Lohmander LS: Molecular markers to monitor outcome and intervention in osteoarthritis (promises, promises). Br J Rheumat 34:599, 1995. PUBMED Abstract

  136. Lohmander LS, Atley LM, Pietka TA, et al: The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 48:3130, 2003. PUBMED Abstract

  137. Lowrie M, Penderis J, McLaughlin M, et al: Steroid responsive meningitis-arteritis: a prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006-2008). J Vet Intern Med 23:862, 2009. PUBMED Abstract

  138. Lu Y, Markel MD, Swain C, Kaplan LD: Development of partial thickness articular cartilage injury in an ovine model. J Orthop Res 24:1978, 2006. PUBMED Abstract

  139. Manicourt DH, Lenz ME, Thonar EJ: Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. J Rheumatol 18:1872, 1991. PUBMED Abstract

  140. Martinez-Subiela S, Ginel PJ, Ceron JJ: Effects of different glucocorticoid treatments on serum acute phase proteins in dogs. Vet Rec 154:814, 2004. PUBMED Abstract

  141. Martinez-Subiela S, Tecles F, Eckersall PD, et al: Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 150:241, 2002. PUBMED Abstract

  142. Matyas JR, Atley L, Ionescu M, et al: Analysis of cartilage biomarkers in the early phases of canine osteoarthritis. Arthritis Rheum 50:543, 2003.

  143. Matyas JR, Ehlers PF, Huang D, Adams ME: The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. Arthritis Rheum 42:993, 1999. PUBMED Abstract

  144. Mazzuca SA, Poole AR, Brandt KD, et al: Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rheumatol 33:1147, 2006. PUBMED Abstract

  145. McCann TM, Ridyard AE, Else RW, et al: Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease. J Small Anim Pract 48:620, 2007. PUBMED Abstract

  146. McDevitt CA, Muir H: Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. J Bone Joint Surg 58:94, 1976. PUBMED Abstract

  147. Meyers SL, Brandt KD, Eilam O: Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee: implications for measurement of synovial fluid markers of osteoarthritis. Arthritis Rheum 38:1085, 1995.

  148. Mischke R, Wohlsein P, Busse L, et al: [Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma]. Schweiz Arch Tierheilkd 140:497, 1998. PUBMED Abstract

  149. Miyamoto T, Fujinaga T, Yamashita K, et al: Changes of serum cytokine activities and other parameters in dogs with experimentally induced endotoxic shock. Jpn J Vet Res 44:107, 1996. PUBMED Abstract

  150. Mohamed-Ali V, Pinkney JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145, 1998. PUBMED Abstract

  151. Müller G, Michel A, Altenburg E: COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connect Tissue Res 39:233, 1998. PUBMED Abstract

  152. Murata H, Shimada N, Yoshioka M: Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 168:28, 2004. PUBMED Abstract

  153. Nakagawa-Tosa N, Morimatsu M, Kawasaki M, et al: Stimulation of haptoglobin synthesis by interleukin-6 and tumor necrosis factor, but not by interleukin-1, in bovine primary cultured hepatocytes. J Vet Med Sci 57:219, 1995. PUBMED Abstract

  154. Nakamura M, Takahashi M, Ohno K, et al: C-reactive protein concentration in dogs with various diseases. J Vet Med Sci 70:127, 2008. PUBMED Abstract

  155. Neame PJ, Barry FP: The link proteins: review. Experientia 49:393, 1993. PUBMED Abstract

  156. Neidhart M, Hauser N, Paulsson M, et al: Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151, 1997. PUBMED Abstract

  157. Nelson F, Dahlberg L, Laverty S, et al: Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102:2115, 1998. PUBMED Abstract

  158. Nemirovskiy OV, Dufield DR, Sunyer T, et al: Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Anal Biochem 361:93, 2007. PUBMED Abstract

  159. Nemirovskiy OV, Sunyer T, Aggarwal P, et al: Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis. Osteoarthritis Cartilage 16:1494, 2008. PUBMED Abstract

  160. Nemzek JA, Agrodnia MD, Hauptman JG: Breed-specific pro-inflammatory cytokine production as a predisposing factor to sepsis in the dog. J Vet Emerg Crit Care 17:368, 2007.

  161. Nganvongpanit K, Itthiarbha A, Ong-Chai S, et al: Evaluation of serum chondroitin sulphate and hyaluronan: biomarkers of osteoarthritis in canine hip dysplasia. J Vet Sci 9:317, 2008. PUBMED Abstract

  162. Nishimoto N: Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18:277, 2006. PUBMED Abstract

  163. Niyibizi C, Wu JJ, Eyre D: The carboxypeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue. Biochem Biophys Acta 916:493, 1987. PUBMED Abstract

  164. O’Brien KD, Brehm BJ, Seeley RJ, et al: Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 90:2244, 2005. PUBMED Abstract

  165. Ogilvie GK, Walters LM, Greeley SG, et al: Concentration of alpha 1-acid glycoprotein in dogs with malignant neoplasia. J Am Vet Med Assoc 203:1144, 1993. PUBMED Abstract

  166. Ohuchi E, Imai K, Fujii Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 72:2446, 1997. PUBMED Abstract

  167. Ohwada K, Tamura K: Usefulness of alpha 1 acid glycoprotein (alpha 1-AG) values in screening pound dogs acquired from animal shelters for experimental use. Jikken Dobutsu 42:627, 1993. PUBMED Abstract

  168. Old LJ: Tumor necrosis factor (TNF). Science 230:630, 1985. PUBMED Abstract

  169. Oldberg A, Antonsson P, Lindblom K, et al: COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267:22346, 1992. PUBMED Abstract

  170. Otabe K, Sugimoto T, Jinbo T, et al: Physiological levels of C-reactive protein in normal canine sera. Vet Res Commun 22:77, 1998. PUBMED Abstract

  171. Otero M, Lago R, Lago F, et al: Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295, 2005. PUBMED Abstract

  172. Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34:141, 1983. PUBMED Abstract

  173. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 111:1805, 2003. PUBMED Abstract

  174. Petersson IF, Boegard T, Svensson B, et al: Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 37:46, 1998. PUBMED Abstract

  175. Plaas AHK, Wong-Palms S, Roughley PJ: Chemical and immunological assay of the nonreducing terminal residues of chondroitin sulphate from human aggrecan. J Biol Chem 272:20603, 1997. PUBMED Abstract

  176. Poole AR: Pathologic manifestations of joint disease in the athletic horse. In McIllwraith CW, Trotter GW, editor: Joint disease in the horse, Philadelphia, 1996, WB Saunders, p 87.

  177. Poole AR, Ionescu M, Fitzcharles MA, Billinghurst RC: The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 294:145, 2004. PUBMED Abstract

  178. Poole AR, Nelson F, Dahlberg L, et al: Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp 70:115, 2003. PUBMED Abstract

  179. Poole R: NIH white paper: biomarkers, the osteoarthritis initiative, Bethesda, MD, 2000, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

  180. Prattay MA, Su JL, Leesnitzer MA, et al: Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthritis Cartilage 14:702, 2006.

  181. Presle N, Pottie P, Dumond H, et al: Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis: contribution of joint tissues to their articular production. Osteoarthritis Cartilage 14:690, 2006. PUBMED Abstract

  182. Qi C, Changlin H: Levels of biomarkers correlate with magnetic resonance imaging progression of knee cartilage degeneration: a study on canine. Knee Surg Sports Traumatol Arthrosc 15:869, 2007. PUBMED Abstract

  183. Radin MJ, Sharkey LC, Holycross BJ: Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol 38:136, 2009. PUBMED Abstract

  184. Ratcliffe A, Beauvais PJ, Fatemah S-M: Synovial fluid analyses detect and differentiate proteoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy. Agents Actions 39:63, 1993. PUBMED Abstract

  185. Rau S, Kohn B, Richter C, et al: Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 36:253, 2007. PUBMED Abstract

  186. Recklies AD, Baillargeon L, White C: Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 41:997, 1998. PUBMED Abstract

  187. Rikihisa Y, Yamamoto S, Kwak I, et al: C-reactive protein and alpha 1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J Clin Microbiol 32:912, 1994. PUBMED Abstract

  188. Robion FC, Doizé B, Bouré L, et al: Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 19:250, 2001. PUBMED Abstract

  189. Rodriguez E, Roughley P: Link protein can retard the degradation of hyaluronan in proteoglycan aggregates. Osteoarthritis Cartilage 14:823, 2006. PUBMED Abstract

  190. Rosenberg K, Olsson H, Mörgelin M, Heinegård D: Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 273:20397, 1998. PUBMED Abstract

  191. Rossert J, de Crombrugghe B: Type I collagen: structure, synthesis and regulation. In Rodan GA, editor: Principles of bone biology, New York, 1996, Academic Press.

  192. Rousseau JC, Zhu Y, Miossec MD, et al: Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 12:440, 2004. PUBMED Abstract

  193. Royce PM, Barnes MJ: Comparative studies on collagen glycosylation in chick skin and bone. Biochim Biophys Acta 498:132, 1977. PUBMED Abstract

  194. Ruaux CG, Pennington HL, Worrall S, et al: Tumor necrosis factor-alpha at presentation in 60 cases of spontaneous canine acute pancreatitis. Vet Immunol Immunopathol 72:369, 1999. PUBMED Abstract

  195. Ryan VH, German AJ, Wood IS, et al: NGF gene expression and secretion by canine adipocytes in primary culture: upregulation by the inflammatory mediators LPS and TN-Falpha. Horm Metab Res 40:861, 2008. PUBMED Abstract

  196. Ryan VH, German AJ, Wood IS, et al: Adipokine expression and secretion by canine adipocytes: stimulation of inflammatory adipokine production by LPS and TNFa (abstract). J Vet Intern Med 23:714, 2009.

  197. Sagawa MM, Nakadomo F, Honjoh T, et al: Correlation between plasma leptin concentration and body fat content in dogs. Am J Vet Res 63:7, 2002. PUBMED Abstract

  198. Salisbury C, Sharif M: Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood. Ann Rheum Dis 56:558, 1997. PUBMED Abstract

  199. Salminen H, Vuorio E, Saamanen AM: Expression of sox9 and type II procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum 44:947, 2001. PUBMED Abstract

  200. Sandell J: Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 114:1307, 1991.

  201. Sasaki K, Ma Z, Khatlani TS, et al: Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci 65:545, 2003. PUBMED Abstract

  202. Saxna T, Heinegard D: Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31:583, 1992.

  203. Senn JJ, Klover PJ, Nowak IA, et al: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391, 2002. PUBMED Abstract

  204. Sharif M, Kirwan J, Charni N, et al: A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis: association with disease progression. Rheumatology 46:938, 2007. PUBMED Abstract

  205. Sharif M, Saxne T, Shepstone L: Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 34:306, 1995. PUBMED Abstract

  206. Sharma RK, Rogojina AT, Chalam KV: Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis 15:60, 2009. PUBMED Abstract

  207. Shi M, Caudle WM, Zhang J: Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis 35:157, 2009. PUBMED Abstract

  208. Shinmei M, Ito K, Matsuyama S, et al: Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collage biosynthesis. Osteoarthritis Cartilage 1:121, 1993. PUBMED Abstract

  209. Slater RR, Bayliss MT, Lachiewicz PF: Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum 38:655, 1995. PUBMED Abstract

  210. Smith KD, Pollacchi A, Field M, et al: The heterogeneity of the glycosylation of alpha-1-acid glycoprotein between the sera and synovial fluid in rheumatoid arthritis. Biomed Chromatogr 16:261, 2002. PUBMED Abstract

  211. Smith PC, Hobisch A, Lin DL, et al: Interleukin-6 and prostate cancer progression. Cytokline Growth Factor Rev 12:33, 2001. PUBMED Abstract

  212. Solter PF, Hoffmann WE, Hungerford LL, et al: Haptoglobin and ceruloplasmin as determinants of inflammation in dogs. Am J Vet Res 52:1738, 1991. PUBMED Abstract

  213. Sorrel JM, Mahmoodian F, Schafer IA, et al: Identification of monoclonal antibodies that recognise novel epitopes in native chondroitin/dermatan sulphate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin. J Histochem Cytochem 38:393, 1990.

  214. Spiers S, May SA, Bennett D, Edwards GB: Cellular sources of proteolytic enzymes in equine joints. Equine Vet J 26:43, 1994. PUBMED Abstract

  215. Spranger J, Kroke A, Mohlig M, et al: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam study. Diabetes 52:812, 2003. PUBMED Abstract

  216. Stephens JM, Lee J, Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971, 1997. PUBMED Abstract

  217. Struglics A, Larsson S, Pratta MA, et al: Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 14:101, 2006. PUBMED Abstract

  218. Tackey E, Lipsky PE, Illei GG: Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 13:339, 2004. PUBMED Abstract

  219. Thompson D, Milford-Ward A, Whicher JT: The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 29(Pt 2):123, 1992. PUBMED Abstract

  220. Thonar EJ, Lenz ME, Klintworth GK: Quantification of keratan sulphate in blood as a marker of cartilage catabolism. Arthritis Rheum 28:1367, 1997.

  221. Thougaard AV, Hellmen E, Pedersen HD, et al: Correlation between alpha 1-acid glycoprotein and total sialic acid in serum from dogs with tumours. Zentralbl Veterinarmed A 46:231, 1999. PUBMED Abstract

  222. Tilg H, Wolf AM: Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 9:245, 2005. PUBMED Abstract

  223. Toda Y, Toda T, Takemura S, et al: Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 25:2181, 1998. PUBMED Abstract

  224. Todhunter RJ: Anatomy and physiology of synovial joints. In McIllwraith CW, editor: Joint disease in the horse, Philadelphia, 1996, WB Saunders, p 1.

  225. Tosa N, Morimatsu M, Nakagawa M, et al: Purification and identification of a serum protein increased by anthelmintic drugs for Dirofilaria immitis in dogs. J Vet Med Sci 55:27, 1993. PUBMED Abstract

  226. Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491, 1994. PUBMED Abstract

  227. Trayhurn P: Adipose tissue in obesity—an inflammatory issue. Endocrinology 146:1003, 2005. PUBMED Abstract

  228. Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329, 2001. PUBMED Abstract

  229. Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347, 2004. PUBMED Abstract

  230. Uhlar CM, Whitehead AS: Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265:501, 1999. PUBMED Abstract

  231. Um JY, Chung HS, Song MY, et al: Association of interleukin-1beta gene polymorphism with body mass index in women. Clin Chem 50:647, 2004. PUBMED Abstract

  232. Van den Steen PE, Proost P, Grillet B, et al: Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379, 2002. PUBMED Abstract

  233. Van Snick J: Interleukin-6: an overview. Annu Rev Immunol 8:253, 1990. PUBMED Abstract

  234. Vannucchi CI, Mirandola RM, Oliveira CM: Acute-phase protein profile during gestation and diestrous: proposal for an early pregnancy test in bitches. Anim Reprod Sci 74:87, 2002. PUBMED Abstract

  235. Vilcek J, Lee TH: Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313, 1991. PUBMED Abstract

  236. Vilim V, Lenz ME, Vytasek R, et al: Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. Arch Biochem Biophys 341:8, 1997. PUBMED Abstract

  237. Volanakis JE: Human C-reactive protein: expression, structure, and function. Mol Immunol 38:189, 2001. PUBMED Abstract

  238. von der Mark K: Structure: biosynthesis and gene regulation of collagens in cartilage and bone. In Seibel MJ, Robins SP, Bilezikian JP, editor: Dynamics of bone and cartilage metabolism, New York, 1999, Academic Press.

  239. Vreugdenhil AC, Dentener MA, Snoek AM, et al: Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 163:2792, 1999. PUBMED Abstract

  240. Waage A, Shalaby R, Terje E: Tumour necrosis factor, interleukin-1, interleukin-6, interleukin-8, and interferon-γ in septic shock. In Kunkel SL, Remick DG, editors: Cytokines in health and diseases, New York, 1992, Marcel Dekker, p 151.

  241. Watanabe A, Morimatsu M, Yoshimatsu K, et al: Isolation of C-reactive protein from cat serum. J Small Anim Pract 33:71, 1992.

  242. Whicher JT, Westacott CI: The acute phase response. In Whicher JT, Evans SW, editors: Biochemistry of inflammation, London, 1992, Kluwer Academic, p 243.

  243. Wilson CG, Palmer AW, Zuo F, et al: Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties. Matrix Biology 26:259, 2006. PUBMED Abstract

  244. Yamamoto S, Miyaji S, Ashida Y, et al: Preparation of anti-canine serum amyloid A (SAA) serum and purification of SAA from canine high-density lipoprotein. Vet Immunol Immunopathol 41:41, 1994. PUBMED Abstract

  245. Yamamoto S, Tagata K, Nagahata H, et al: Isolation of canine C-reactive protein and characterization of its properties. Vet Immunol Immunopathol 30:329, 1992. PUBMED Abstract

  246. Yamashita K, Fujinaga T, Miyamoto T, et al: Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. J Vet Med Sci 56:487, 1994. PUBMED Abstract

  247. Yoshioka M, Watanabe A, Shimada N, et al: Regulation of haptoglobin secretion by recombinant bovine cytokines in primary cultured bovine hepatocytes. Domest Anim Endocrinol 23:425, 2002.

  248. Yule TD, Roth MB, Dreier K, et al: Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine 15:720, 1997. PUBMED Abstract

  249. Zhu Y, Sandell LJ, Matyas JR: Differential expression of type IIA collagen in early osteoarthritis. Trans Orthop Res Soc 26:664, 2001.
1   2   3   4   5   6   7   8   9   ...   55

Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət